Paper41286375
Impact of single-cell cell cycle regulation of intercellular communication on the prognosis of hepatocellular carcinoma in the tumor microenvironment.
Hu C and 3 others. Clin Exp Med, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Impact of single-cell cell cycle regulation of intercellular communication on the prognosis of hepatocellular carcinoma in the tumor microenvironment. Papers, record 41286375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41286375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of single-cell cell cycle regulation of intercellular communication on the prognosis of hepatocellular carcinoma in the tumor microenvironment.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Cell Communication | Major topic |
| Cell Cycle | Major topic |
| Humans | |
| Prognosis | |
| Single-Cell Analysis | |
| Gene Expression Regulation, Neoplastic | |
| Gene Regulatory Networks | |
| Gene Expression Profiling |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40362682 | Precise Electromagnetic Modulation of the Cell Cycle and Its Applications in Cancer Therapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362682 | PubMed |
| 2 | 40307557 | Cell cycle duration determines oncogenic transformation capacity. | Nature | 2025 | https://conductscience.org/library/papers/40307557 | PubMed |
| 3 | 36272973 | PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer. | Nat Commun | 2022 | https://conductscience.org/library/papers/36272973 | PubMed |
| 4 | 38460375 | Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/38460375 | PubMed |
| 5 | 38477904 | Anatomic Liver Resection Based on Portal Territory With Margin Priority for Hepatocellular Carcinoma. | JAMA Surg | 2024 | https://conductscience.org/library/papers/38477904 | PubMed |
| 6 | 35159214 | Multistability in Macrophage Activation Pathways and Metabolic Implications. | Cells | 2022 | https://conductscience.org/library/papers/35159214 | PubMed |
| 7 | 38470957 | Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function. | Sci Signal | 2024 | https://conductscience.org/library/papers/38470957 | PubMed |
| 8 | 38108634 | Adjuvant and neoadjuvant therapies for hepatocellular carcinoma. | Hepatology | 2025 | https://conductscience.org/library/papers/38108634 | PubMed |
| 9 | 36376165 | Crosstalk between glucose metabolism, lactate production and immune response modulation. | Cytokine Growth Factor Rev | 2022 | https://conductscience.org/library/papers/36376165 | PubMed |
| 10 | 38483380 | Quantification of Treatment Effect of Tislelizumab vs Sorafenib for Hepatocellular Carcinoma. | JAMA Oncol | 2024 | https://conductscience.org/library/papers/38483380 | PubMed |
| 11 | 38420949 | Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy. | ACS Nano | 2024 | https://conductscience.org/library/papers/38420949 | PubMed |
| 12 | 30045663 | Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma. | Cell Cycle | 2018 | https://conductscience.org/library/papers/30045663 | PubMed |
| 13 | 40399682 | Multigenerational cell tracking of DNA replication and heritable DNA damage. | Nature | 2025 | https://conductscience.org/library/papers/40399682 | PubMed |
| 14 | 38242198 | Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38242198 | PubMed |
| 15 | 31698319 | Huganpian, a traditional chinese medicine, inhibits liver cancer growth in vitro and in vivo by inducing autophagy and cell cycle arrest. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/31698319 | PubMed |
| 16 | 38479553 | Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38479553 | PubMed |
| 17 | 38463798 | Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME). | Heliyon | 2024 | https://conductscience.org/library/papers/38463798 | PubMed |
| 18 | 37056933 | Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37056933 | PubMed |
| 19 | 38464783 | Pyrimethamine upregulates BNIP3 to interfere SNARE-mediated autophagosome-lysosomal fusion in hepatocellular carcinoma. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/38464783 | PubMed |
| 20 | 39924553 | Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle. | Nat Commun | 2025 | https://conductscience.org/library/papers/39924553 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41286375
GET https://conductscience.org/api/papers/v1/41286375/references?page=2